ArticleOncoTargets and therapy2019

Reactive Oxygen Species Modulator 1 As An Adverse Prognostic Marker In Stage III Non-Small Cell Lung Cancer Treated With Radiotherapy: A Retrospective Pilot Study.

Moonkyoo Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.